載入...

Bactericidal Activity and Resistance Development Profiling of Dalbavancin

Dalbavancin, a semisynthetic lipoglycopeptide being developed for the treatment of skin and skin structure infections (SSSIs), has a half-life of 5 to 7 days in humans and offers promise for a convenient weekly dosing regimen. We studied the in vitro bactericidal activity of dalbavancin against targ...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Goldstein, Beth P., Draghi, Deborah C., Sheehan, Daniel J., Hogan, Patricia, Sahm, Daniel F.
格式: Artigo
語言:Inglês
出版: American Society for Microbiology 2007
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC1855483/
https://ncbi.nlm.nih.gov/pubmed/17220411
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00620-06
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!